An operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination with GS-4812Versus Biktarvy in Treatment-Naive People With HIV-1
Lay Description
Category
- Child Health
- Nervous System
- IRB Number
- STUDY00000913
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Hillary Johnson
210-450-7612
johnsonh4@uthscsa.edu
Irma Scholler
210-450-3150
scholler@uthscsa.edu
Principal Investigator
Barbara Taylor